Chlorhexidine gluconate: To bathe or not to bathe?

Critical Care Nursing Quarterly

Volumn 36, Issue 2, 2013, Pages 233-236

  Rubin, Caroline ^a   Louthan, Rufina Bavin ^a   Wessels, Erica ^a   McGowan, Mary Bridgid ^a   Downer, Shantee ^a   Maiden, Jeanne ^a  

^a POINT LOMA NAZARENE UNIVERSITY   (United States)

Author keywords

bathing; chlorhexidine gluconate; hospital acquired infections

Indexed keywords

CHLORHEXIDINE GLUCONATE; SOAP; WATER;

ARTICLE; BACTERIAL SUPERINFECTION; BACTERICIDAL ACTIVITY; BATH; BLOODSTREAM INFECTION; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATIENT SAFETY; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA; WOUND HEALING;

ANTI-INFECTIVE AGENTS, LOCAL; BATHS; CHLORHEXIDINE; CROSS INFECTION; HUMANS;

EID: 84875188341     PISSN: 08879303     EISSN: 15505111     Source Type: Journal    
DOI: 10.1097/CNQ.0b013e31828404d1     Document Type: Article

References (12)

1. Evans H, Dellit T, Chan J, Nathens A, Maier R, Cuschieri J. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg. 2010;145(3):240. Retrieved from ProQuest Nursing & Allied Health Source.
2. Holder C, Zellinger M. Daily bathing with Chlorhex-idine in the ICU to prevent central line-associated bloodstream infections. J Clin Outcomes Manag. 2009;16(11):509-513.
3. Burlington B; Food and Drug Administration, Public health. FDA Public Health Notice: Potential Hyper-sensitivity Reactions to Chlorhexidine- Impregnated Medical Devices. Silver Spring, MD: Center for Devices and Radiological Health, US Food and Drug Administration; 1998.
4. Stokowski LA. Chlorhexidine in Healthcare: Your Questions Answered. New York, NY: Medscape Nurses. 2010.
5. Mayo Clinic. Chlorhexidine (topical application route). MayoClinic.com. 2011:1-5.
6. The Joint Commission. Hospital National Patient Safety Goals. Oakbrook Terrace, IL: The Joint Commission; 2011.
7. Hassen SM, Mobarak EH, Fawzi EM. The efficacy of different regimens of chlorhexidine as an antimicro-bial agent for a group of Egyptians. J Egypt Public Health Assoc. 2008;83(5/6):435-450.
8. Akhtar, SR. Should ICU patient be bathed daily with chlorhexidine? Critical Care Alert. 2011; 94-95.
9. Edgeworth JD. Has decolonization played a central role in the decline in UK methicillin-resistant staphy-lococcus aureus transmission? A focus on evidence from the intensive care. J Antimicrob Chemother. 2011;66(3):41-46.
10. Bleasdale SC, Trick WE, Gonzalez IM, Lysles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhex-idine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med. 2007;167(19):2073-2079. Retrieved October 24, 2010, from CINAHL.
11. Climo MW, Sepkowitz KA, Zuccotti G, et al. Daily bathing with chlorhexidine on the acquisition of MRSA, VRE, and BSI [Electronic version]. Crit Care Med. 2009;37(6):1858-1865.
12. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the biobur-den of vancomycin-resistant enterococci. Arch Intern Med. 2009;166:306-312.